Clinical Trials Browser

Phase 2 × Rectal Neoplasms × pegfilgrastim × Clear all

NCT00094809 2018-10-17

Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon Cancer

Phase 2 Completed

252 enrolled 19 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms